Literature DB >> 23695450

Early T-cell precursor acute lymphoblastic leukaemia.

J Erika Haydu1, Adolfo A Ferrando.   

Abstract

PURPOSE OF REVIEW: Early T-cell precursor (ETP) leukaemias have been recently recognized as a form of T-cell acute lymphoblastic leukaemia (T-ALL) with a poor prognosis. The purpose of this review is to outline the most recent advances in the biology, genetics and prognostic significance of this aggressive disease. RECENT
FINDINGS: Detailed immunophenotypic analyses have defined ETP T-ALLs as a distinct group of T-ALL with a poor prognosis. Transcriptionally, ETP T-ALLs and early immature T-ALLs, a broader group of tumours characterized by very early arrest in T-cell differentiation, are most related to haematopoietic stem cells and myeloid progenitors. Consistently, these leukaemias show lower frequencies of prototypical T-ALL lesions such as CDKN2A/B deletions and activating mutations in NOTCH1 and show a higher prevalence of mutations typically associated with the pathogenesis of acute myeloid leukaemias (AMLs).
SUMMARY: ETP and early immature T-ALLs are characterized by a very early differentiation arrest and show unique genetic and transcriptional features that overlap both with T-ALL and with AML. Given the unique biology and poor prognosis associated with the ETP T-ALL group, there is an urgent need of new tailored therapeutic strategies for the treatment of this disease.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23695450      PMCID: PMC3886681          DOI: 10.1097/MOH.0b013e3283623c61

Source DB:  PubMed          Journal:  Curr Opin Hematol        ISSN: 1065-6251            Impact factor:   3.284


  15 in total

1.  Absence of biallelic TCRgamma deletion predicts early treatment failure in pediatric T-cell acute lymphoblastic leukemia.

Authors:  Alejandro Gutierrez; Suzanne E Dahlberg; Donna S Neuberg; Jianhua Zhang; Ruta Grebliunaite; Takaomi Sanda; Alexei Protopopov; Valeria Tosello; Jeffery Kutok; Richard S Larson; Michael J Borowitz; Mignon L Loh; Adolfo A Ferrando; Stuart S Winter; Charles G Mullighan; Lewis B Silverman; Lynda Chin; Stephen P Hunger; Stephen E Sallan; A Thomas Look
Journal:  J Clin Oncol       Date:  2010-07-19       Impact factor: 44.544

2.  Clinical significance of early T-cell precursor acute lymphoblastic leukaemia: results of the Tokyo Children's Cancer Study Group Study L99-15.

Authors:  Takeshi Inukai; Nobutaka Kiyokawa; Dario Campana; Elaine Coustan-Smith; Akira Kikuchi; Miyuki Kobayashi; Hiroyuki Takahashi; Katsuyoshi Koh; Atsushi Manabe; Masaaki Kumagai; Koichiro Ikuta; Yasuhide Hayashi; Masahiro Tsuchida; Kanji Sugita; Akira Ohara
Journal:  Br J Haematol       Date:  2011-11-30       Impact factor: 6.998

3.  High expression of the ETS transcription factor ERG predicts adverse outcome in acute T-lymphoblastic leukemia in adults.

Authors:  Claudia D Baldus; Thomas Burmeister; Peter Martus; Stefan Schwartz; Nicola Gökbuget; Clara D Bloomfield; Dieter Hoelzer; Eckhard Thiel; Wolf K Hofmann
Journal:  J Clin Oncol       Date:  2006-09-05       Impact factor: 44.544

4.  The genetic basis of early T-cell precursor acute lymphoblastic leukaemia.

Authors:  Jinghui Zhang; Li Ding; Linda Holmfeldt; Gang Wu; Sue L Heatley; Debbie Payne-Turner; John Easton; Xiang Chen; Jianmin Wang; Michael Rusch; Charles Lu; Shann-Ching Chen; Lei Wei; J Racquel Collins-Underwood; Jing Ma; Kathryn G Roberts; Stanley B Pounds; Anatoly Ulyanov; Jared Becksfort; Pankaj Gupta; Robert Huether; Richard W Kriwacki; Matthew Parker; Daniel J McGoldrick; David Zhao; Daniel Alford; Stephen Espy; Kiran Chand Bobba; Guangchun Song; Deqing Pei; Cheng Cheng; Stefan Roberts; Michael I Barbato; Dario Campana; Elaine Coustan-Smith; Sheila A Shurtleff; Susana C Raimondi; Maria Kleppe; Jan Cools; Kristin A Shimano; Michelle L Hermiston; Sergei Doulatov; Kolja Eppert; Elisa Laurenti; Faiyaz Notta; John E Dick; Giuseppe Basso; Stephen P Hunger; Mignon L Loh; Meenakshi Devidas; Brent Wood; Stuart Winter; Kimberley P Dunsmore; Robert S Fulton; Lucinda L Fulton; Xin Hong; Christopher C Harris; David J Dooling; Kerri Ochoa; Kimberly J Johnson; John C Obenauer; William E Evans; Ching-Hon Pui; Clayton W Naeve; Timothy J Ley; Elaine R Mardis; Richard K Wilson; James R Downing; Charles G Mullighan
Journal:  Nature       Date:  2012-01-11       Impact factor: 49.962

5.  Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia.

Authors:  Elaine Coustan-Smith; Charles G Mullighan; Mihaela Onciu; Frederick G Behm; Susana C Raimondi; Deqing Pei; Cheng Cheng; Xiaoping Su; Jeffrey E Rubnitz; Giuseppe Basso; Andrea Biondi; Ching-Hon Pui; James R Downing; Dario Campana
Journal:  Lancet Oncol       Date:  2009-01-13       Impact factor: 41.316

6.  Early T-cell precursor leukemia: a subtype of high risk childhood acute lymphoblastic leukemia.

Authors:  Meilin Ma; Xiang Wang; Jingyan Tang; Huiliang Xue; Jing Chen; Ci Pan; Hua Jiang; Shuhong Shen
Journal:  Front Med       Date:  2012-10-12       Impact factor: 4.592

Review 7.  Acute lymphoblastic leukaemia.

Authors:  Ching-Hon Pui; Leslie L Robison; A Thomas Look
Journal:  Lancet       Date:  2008-03-22       Impact factor: 79.321

8.  Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia.

Authors:  Adolfo A Ferrando; Donna S Neuberg; Jane Staunton; Mignon L Loh; Christine Huard; Susana C Raimondi; Fred G Behm; Ching Hon Pui; James R Downing; D Gary Gilliland; Eric S Lander; Todd R Golub; A Thomas Look
Journal:  Cancer Cell       Date:  2002-02       Impact factor: 31.743

9.  Clinical and molecular characterization of early T-cell precursor leukemia: a high-risk subgroup in adult T-ALL with a high frequency of FLT3 mutations.

Authors:  M Neumann; S Heesch; N Gökbuget; S Schwartz; C Schlee; O Benlasfer; N Farhadi-Sartangi; J Thibaut; T Burmeister; D Hoelzer; W-K Hofmann; E Thiel; C D Baldus
Journal:  Blood Cancer J       Date:  2012-01-27       Impact factor: 11.037

10.  ETV6 mutations in early immature human T cell leukemias.

Authors:  Pieter Van Vlierberghe; Alberto Ambesi-Impiombato; Arianne Perez-Garcia; J Erika Haydu; Isaura Rigo; Michael Hadler; Valeria Tosello; Giusy Della Gatta; Elisabeth Paietta; Janis Racevskis; Peter H Wiernik; Selina M Luger; Jacob M Rowe; Montserrat Rue; Adolfo A Ferrando
Journal:  J Exp Med       Date:  2011-12-12       Impact factor: 14.307

View more
  30 in total

Review 1.  Developmental gene networks: a triathlon on the course to T cell identity.

Authors:  Mary A Yui; Ellen V Rothenberg
Journal:  Nat Rev Immunol       Date:  2014-08       Impact factor: 53.106

2.  Poor Response to Standard Chemotherapy in Early T-precursor (ETP)-ALL: A Subtype of T-ALL Associated with Unfavourable Outcome: A Brief Report.

Authors:  Nida Iqbal; Atul Sharma; Vinod Raina; Lalit Kumar; Sameer Bakhshi; Rajive Kumar; Smeeta Gajendra
Journal:  Indian J Hematol Blood Transfus       Date:  2014-01-19       Impact factor: 0.900

3.  KMT2E-ASNS: a novel relapse-specific fusion gene in early T-cell precursor acute lymphoblastic leukemia.

Authors:  Fida Khater; Mathieu Lajoie; Sylvie Langlois; Jasmine Healy; Sonia Cellot; Chantal Richer; Patrick Beaulieu; Pascal St-Onge; Virginie Saillour; Mark Minden; Monia Marzouki; Maja Krajinovic; Henrique Bittencourt; Daniel Sinnett
Journal:  Blood       Date:  2017-01-09       Impact factor: 22.113

Review 4.  Can one target T-cell ALL?

Authors:  Adolfo Ferrando
Journal:  Best Pract Res Clin Haematol       Date:  2018-10-17       Impact factor: 3.020

Review 5.  Recent Advances in the Biology and Treatment of T Cell Acute Lymphoblastic Leukemia.

Authors:  Mehrdad Hefazi; Mark R Litzow
Journal:  Curr Hematol Malig Rep       Date:  2018-08       Impact factor: 3.952

6.  Posttranslational Regulation of the Exon Skipping Machinery Controls Aberrant Splicing in Leukemia.

Authors:  Yalu Zhou; Cuijuan Han; Eric Wang; Adam H Lorch; Valentina Serafin; Byoung-Kyu Cho; Blanca T Gutierrez Diaz; Julien Calvo; Celestia Fang; Alireza Khodadadi-Jamayran; Tommaso Tabaglio; Christian Marier; Anna Kuchmiy; Limin Sun; George Yacu; Szymon K Filip; Qi Jin; Yoh-Hei Takahashi; David R Amici; Emily J Rendleman; Radhika Rawat; Silvia Bresolin; Maddalena Paganin; Cheng Zhang; Hu Li; Irawati Kandela; Yuliya Politanska; Hiam Abdala-Valencia; Marc L Mendillo; Ping Zhu; Bruno Palhais; Pieter Van Vlierberghe; Tom Taghon; Iannis Aifantis; Young Ah Goo; Ernesto Guccione; Adriana Heguy; Aristotelis Tsirigos; Keng Boon Wee; Rama K Mishra; Francoise Pflumio; Benedetta Accordi; Giuseppe Basso; Panagiotis Ntziachristos
Journal:  Cancer Discov       Date:  2020-05-22       Impact factor: 39.397

7.  Idh1 mutations contribute to the development of T-cell malignancies in genetically engineered mice.

Authors:  Zhenyue Hao; Rob A Cairns; Satoshi Inoue; Wanda Y Li; Yi Sheng; François Lemonnier; Andrew Wakeham; Bryan E Snow; Carmen Dominguez-Brauer; Jing Ye; Dana M Larsen; Kimberly S Straley; Erica R Tobin; Rohini Narayanaswamy; Philippe Gaulard; Tak W Mak
Journal:  Proc Natl Acad Sci U S A       Date:  2016-01-19       Impact factor: 11.205

Review 8.  Treatment of pediatric acute lymphoblastic leukemia.

Authors:  Stacy L Cooper; Patrick A Brown
Journal:  Pediatr Clin North Am       Date:  2014-10-18       Impact factor: 3.278

Review 9.  Two cases of phenotypic switch of primary cutaneous T cell lymphoma after treatment with an aggressive course and review of the literature.

Authors:  Etan Marks; Yang Shi; Yanhua Wang
Journal:  Virchows Arch       Date:  2019-06-19       Impact factor: 4.064

10.  Loss of Capicua alters early T cell development and predisposes mice to T cell lymphoblastic leukemia/lymphoma.

Authors:  Qiumin Tan; Lorenzo Brunetti; Maxime W C Rousseaux; Hsiang-Chih Lu; Ying-Wooi Wan; Jean-Pierre Revelli; Zhandong Liu; Margaret A Goodell; Huda Y Zoghbi
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-30       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.